Robert F. Lemanske, Jr., MD, is Professor of Pediatrics and Medicine at the University of Wisconsin School of Medicine and Public Health in Madison, where he is Head of the Division of Pediatric Allergy, Immunology, and Rheumatology. He is currently the chair of the Allergy and Immunology Conjoint Program at the University of Wisconsin School of Medicine and Public Health and the Director of the Morris Institute of Respiratory Research.
His research interests have focused primarily on the pathophysiology and treatment of asthma including mechanisms underlying pulmonary late phase reactions, virus-induced airway dysfunction, and asthma inception in infants and young children. He is currently one of the principal investigators of AsthmaNet, an asthma consortium designed to evaluate new and existing therapies for asthma in children and adults funded by the National Heart Lung and Blood Institute (NHLBI). In addition, he is currently the principal investigator of a Program Project Grant from the NHLBI that is studying the contributions of both genetic (atopy) and environmental (viral infections) factors on the origins of asthma and allergic disease in a birth cohort termed COAST (Childhood Origins of ASThma). Finally, he is a co-principal investigator on an NHLBI-funded grant to evaluate factors influencing the development of both the lung and the immune system using data generated both in humans and in rodent models.
Dr. Lemanske has published his research in the Journal of Immunology, Journal of Allergy and Clinical Immunology, New England Journal of Medicine, Journal of the American Medical Association, Pediatric Research, Journal of Pediatrics, American Review of Respiratory and Critical Care Medicine, and Immunology. He was appointed to the National Heart Lung and Blood Institute's Advisory Council for decisions regarding extramural funding of basic and clinical research (2003-2007). He also has served on the expert panel for the development of guidelines for the treatment of childhood asthma in Canada and the United States (National Asthma Education and Prevention Program) (NAEPP) and is currently a member of the Scientific Committee of the National Asthma Education and Prevention Program.
A Fellow of both the American Academy of Allergy, Asthma & Immunology and the American Academy of Pediatrics, Dr. Lemanske is also a member of the American Thoracic Society, the American Association of Immunologists, and the Society for Pediatric Research. Honors Dr. Lemanske has received include the NIAID Allergic Disease Academic Award, membership in the Society for Pediatric Research.
Additional Research Activities
- AsthmaNet-a multicenter grant funded by the National Heart Lung and Blood Institute to design, implement, and conduct asthma treatment trials in both children and adults. Ancillary studies linked to these treatment trials will focus on basic mechanisms to better understand human variability in response to various treatments.
- CARE Network – Madison Clinical Center/NIH-NHLBI
Childhood Asthma: Initiation and InterventionA collaborative pediatric asthma research network to encourage and facilitate the opportunity to advance the field in the diagnosis, pathogenesis, and treatment of children and adolescents with asthma.
- ACRN – Treatment of Severe Persistent Asthma/NIH-NHLBI
To develop an asthma clinical research network for the purpose of designing protocols to evaluate new drug therapies for asthma.
- Invited panel member. NAEPP Science Base Committee Meeting. Bethesda, Maryland. 2000- present
- American Academy of Allergy, Asthma & Immunology Grant Review Committee. 2002-present
- Global Initiative for Asthma (GINA) Science Based Committee. 2007-present
- Member, Medical Education and Research Committee, University of Wisconsin School of Medicine and Public Health. 2009-present
- Member, Academic Planning Council, University of Wisconsin School of Medicine and Public Health